Read

Members
Client Resources
Pharmacy + Provider Resources
Drug Recalls
Events

Who we are
Our solutions
Read, watch, listen
Pharmacy
Careers

Members
Client Resources
Pharmacy + Provider Resources
Drug Recalls
Events

Home
Read, watch, listen
Read

Explore what's trending at Prime

https://primetherapeutics.com/w/prime-therapeutics-appoints-public-affairs-veteran-katie-payne-as-chief-external-affairs-officer Example Link

Press Releases

Prime Therapeutics appoints public affairs veteran Katie Payne as chief external affairs officer

November 13, 2025

https://primetherapeutics.com/w/high-cost-therapy-profile-november-2025 /high-cost-therapy-profile-november-2025

Research & Publications

High-Cost Therapy Profile: November 2025

November 14, 2025

https://primetherapeutics.com/w/oncology-insights-november-2025 /oncology-insights-november-2025

Research & Publications

Oncology Insights: November 2025

November 14, 2025

https://primetherapeutics.com/w/prime-careers-spotlight-november-2025 /prime-careers-spotlight-november-2025

Stories

Prime Careers Spotlight: November 2025

November 14, 2025

The Latest

Categories

PA Sub-Categories

https://primetherapeutics.com/w/prime-therapeutics-appoints-public-affairs-veteran-katie-payne-as-chief-external-affairs-officer

Prime Therapeutics appoints public affairs veteran Katie Payne as chief external affairs officer

November 13, 2025

https://primetherapeutics.com/w/prime-therapeutics-supports-fda-s-updated-biosimilar-recommendations

Prime Therapeutics supports FDA’s updated biosimilar recommendations

October 30, 2025

https://primetherapeutics.com/w/prime-therapeutics-to-present-latest-managed-care-pharmacy-insights-at-amcp-nexus-2025

Prime Therapeutics to present latest managed care pharmacy insights at AMCP Nexus 2025

October 27, 2025

https://primetherapeutics.com/w/prime-therapeutics-scales-judi-platform-implementations-with-support-from-pwc

Prime Therapeutics Scales Judi® Platform Implementations with Support from PwC

October 01, 2025

https://primetherapeutics.com/w/what-s-driving-medical-benefit-spend-prime-therapeutics-trend-report-shares-new-clues

What's driving medical benefit spend? Prime Therapeutics trend report shares new clues

September 04, 2025

https://primetherapeutics.com/w/prime-therapeutics-leading-research-shows-only-1-in-12-remain-on-a-glp-1-drug-for-obesity-at-three-years

Prime Therapeutics’ leading research shows only 1 in 12 remain on a GLP-1 drug for obesity at three years

June 25, 2025

Showing 1 to 6 of 41

Categories

PA Sub-Categories

https://primetherapeutics.com/w/end-of-year-outlook-what-s-next-for-drug-approvals-pipeline-and-innovation

End-of-year outlook: What’s next for drug approvals, pipeline, and innovation

November 10, 2025

https://primetherapeutics.com/w/integrated-oncology-insights-navigating-the-medical-and-pharmacy-claims-landscape

Integrated oncology insights: Navigating the medical and pharmacy claims landscape

October 23, 2025

https://primetherapeutics.com/w/how-to-safely-dispose-of-medications-on-national-drug-take-back-day

How to safely dispose of medications on National Drug Take Back Day

October 20, 2025

https://primetherapeutics.com/w/15-years-of-insight-prime-s-medical-pharmacy-trend-report-a-must-read-for-payers

15 years of insight: Prime’s Medical Pharmacy Trend Report — A must-read for payers

October 02, 2025

https://primetherapeutics.com/w/abby-kim-leads-the-charge-in-advancing-lung-cancer-care

Abby Kim leads the charge in advancing lung cancer care

October 01, 2025

https://primetherapeutics.com/w/making-sense-of-most-favored-nation-and-other-proposed-health-care-policies

Making sense of most favored nation and other proposed health care policies

September 30, 2025

Showing 1 to 6 of 67

Categories

PA Sub-Categories

https://primetherapeutics.com/w/prime-careers-spotlight-november-2025 /prime-careers-spotlight-november-2025

Prime Careers Spotlight: November 2025

November 14, 2025

https://primetherapeutics.com/w/prime-therapeutics-introduces-new-publication-cell-and-gene-pipeline-outlook

Prime Therapeutics introduces new publication, Cell & Gene Pipeline Outlook

November 12, 2025

https://primetherapeutics.com/w/amcp-nexus-2025-radiopharmaceuticals-revolutionize-cancer-care

AMCP Nexus 2025: Radiopharmaceuticals revolutionize cancer care

October 30, 2025

https://primetherapeutics.com/w/amcp-nexus-2025-a-deep-dive-into-prostate-cancer-treatment

AMCP Nexus 2025: A deep dive into prostate cancer treatment

October 30, 2025

https://primetherapeutics.com/w/recap-academy-of-managed-care-pharmacy-amcp-nexus-2025

RECAP: Academy of Managed Care Pharmacy (AMCP) Nexus 2025

October 30, 2025

https://primetherapeutics.com/w/treatment-breakthroughs-and-managed-care-innovations-highlighted-at-amcp-nexus-2025

Treatment breakthroughs and managed care innovations highlighted at AMCP Nexus 2025

October 29, 2025

Showing 1 to 6 of 157

Categories

PA Sub-Categories

https://primetherapeutics.com/w/prime-presents-at-73rd-annual-roy-a-bowers-pharmaceutical-conference-on-nov-11

Prime presents at 73rd annual Roy A. Bowers Pharmaceutical Conference on Nov. 11

October 29, 2025

https://primetherapeutics.com/w/prime-presents-at-hlth-usa-conference-on-oct-20

Prime presents at HLTH USA conference on Oct. 20

October 17, 2025

https://primetherapeutics.com/w/prime-presents-2025-medical-pharmacy-trend-report-webcast-on-oct-13

Prime presents 2025 Medical Pharmacy Trend Report webcast on Oct. 13

September 23, 2025

https://primetherapeutics.com/w/prime-expert-presents-at-the-most-favored-nation-mandate-webinar

Prime expert presents at “The Most Favored Nation Mandate” webinar on Sept. 10

September 02, 2025

https://primetherapeutics.com/w/prime-presents-at-national-association-of-specialty-pharmacy-nasp-annual-meeting-from-sept-14-17

Prime presents at National Association of Specialty Pharmacy (NASP) annual meeting from Sept. 14–17

August 25, 2025

https://primetherapeutics.com/w/prime-presents-at-isg-digital-business-summit-on-nov-14

Prime presents at ISG Digital Business Summit on Nov. 14

November 05, 2024

Showing 1 to 6 of 37

Categories

PA Sub-Categories

https://primetherapeutics.com/w/help-net-security-healthcare-security-is-broken-because-its-systems-can-t-talk-to-each-other https://www.helpnetsecurity.com/2025/11/13/cameron-kracke-prime-therapecutics-healthcare-security-ecosystem/

Help Net Security: Healthcare security is broken because its systems can’t talk to each other

November 13, 2025

https://primetherapeutics.com/w/ajmc-bridging-the-gap-between-cutting-edge-cancer-care-and-equitable-access https://www.ajmc.com/view/bridging-the-gap-between-cutting-edge-cancer-care-and-equitable-access

AJMC: Bridging the Gap Between Cutting-Edge Cancer Care and Equitable Access

November 10, 2025

https://primetherapeutics.com/w/drug-store-news-emblemhealth-taps-amazon-pharmacy-for-new-pharmacy-benefit https://drugstorenews.com/emblemhealth-taps-amazon-pharmacy-new-pharmacy-benefit

Drug Store News: EmblemHealth taps Amazon Pharmacy for new pharmacy benefit

November 03, 2025

https://primetherapeutics.com/w/managed-healthcare-executive-automated-prior-authorization-speeds-approval-of-glp-1-therapies-amcp-nexus-2025 https://www.managedhealthcareexecutive.com/view/automated-prior-authorization-speeds-approval-of-glp-1-therapies-amcp-nexus-2025

Managed Healthcare Executive: Automated Prior Authorization Speeds Approval of GLP-1 Therapies | AMCP Nexus 2025

October 31, 2025

https://primetherapeutics.com/w/managed-healthcare-executive-payers-are-bracing-for-the-specialty-trend-of-the-future-amcp-nexus-2025 https://www.managedhealthcareexecutive.com/view/payers-are-bracing-for-the-specialty-trend-of-the-future-amcp-nexus-2025

Managed Healthcare Executive: Payers Are Bracing for the Specialty Trend of the Future | AMCP Nexus 2025

October 30, 2025

https://primetherapeutics.com/w/fierce-healthcare-prime-therapeutics-takes-sempre-health-s-pricing-model-nationwide https://www.fiercehealthcare.com/payers/prime-therapeutics-takes-sempre-healths-pricing-model-nationwide

Fierce Healthcare: Prime Therapeutics takes Sempre Health's pricing model nationwide

October 30, 2025

Showing 1 to 6 of 127

Categories

PA Research & Publications

https://primetherapeutics.com/w/high-cost-therapy-profile-november-2025 /high-cost-therapy-profile-november-2025

High-Cost Therapy Profile: November 2025

November 14, 2025

https://primetherapeutics.com/w/oncology-insights-november-2025 /oncology-insights-november-2025

Oncology Insights: November 2025

November 14, 2025

https://primetherapeutics.com/w/cell-gene-pipeline-outlook-november-2025 /cell-gene-pipeline-outlook-november-2025

Cell & Gene Pipeline Outlook: November 2025

November 12, 2025

https://primetherapeutics.com/w/trending-topics-drug-approvals-november-2025 /trending-topics-drug-approvals-november-2025

Five research posters presented at AMCP Nexus 2025

October 30, 2025

https://primetherapeutics.com/w/quarterly-drug-approvals-october-2025 /quarterly-drug-approvals-october-2025

Quarterly Drug Approvals: October 2025

October 30, 2025

Showing 1 to 6 of 184

Login Portals

Members and Consumers
Clients and Health Plans
Pharmacy + Provider Resources

Compliance / Legal

Privacy Policy
Notice of Privacy Practices
Terms of Use
Nondiscrimination + Languages
Subrogation

Company

About us
Careers
News
Media

Read &#8211; News, Research &amp; Insights from Prime Therapeutics - Prime Therapeutics

About us

Corporate social responsibility

Solutions overview

Modern technology

Drug access

Clinical solutions

Condition management

Specialty drug management

Government solutions

Single-state programs

Watch

Listen

Home Delivery

Specialty Pharmacy

Navigate to

Back

Back

Back

Back

Explore what's trending at Prime

Prime Therapeutics appoints public affairs veteran Katie Payne as chief external affairs officer

High-Cost Therapy Profile: November 2025

Oncology Insights: November 2025

Prime Careers Spotlight: November 2025

The Latest

Prime Therapeutics appoints public affairs veteran Katie Payne as chief external affairs officer

Prime Therapeutics supports FDA’s updated biosimilar recommendations

Prime Therapeutics to present latest managed care pharmacy insights at AMCP Nexus 2025

Prime Therapeutics Scales Judi® Platform Implementations with Support from PwC

What's driving medical benefit spend? Prime Therapeutics trend report shares new clues

Prime Therapeutics’ leading research shows only 1 in 12 remain on a GLP-1 drug for obesity at three years

End-of-year outlook: What’s next for drug approvals, pipeline, and innovation

Integrated oncology insights: Navigating the medical and pharmacy claims landscape

How to safely dispose of medications on National Drug Take Back Day

15 years of insight: Prime’s Medical Pharmacy Trend Report — A must-read for payers

Abby Kim leads the charge in advancing lung cancer care

Making sense of most favored nation and other proposed health care policies

Prime Careers Spotlight: November 2025

Prime Therapeutics introduces new publication, Cell & Gene Pipeline Outlook

AMCP Nexus 2025: Radiopharmaceuticals revolutionize cancer care

AMCP Nexus 2025: A deep dive into prostate cancer treatment

RECAP: Academy of Managed Care Pharmacy (AMCP) Nexus 2025

Treatment breakthroughs and managed care innovations highlighted at AMCP Nexus 2025

Prime presents at 73rd annual Roy A. Bowers Pharmaceutical Conference on Nov. 11

Prime presents at HLTH USA conference on Oct. 20

Prime presents 2025 Medical Pharmacy Trend Report webcast on Oct. 13

Prime expert presents at “The Most Favored Nation Mandate” webinar on Sept. 10

Prime presents at National Association of Specialty Pharmacy (NASP) annual meeting from Sept. 14–17

Prime presents at ISG Digital Business Summit on Nov. 14

Help Net Security: Healthcare security is broken because its systems can’t talk to each other

AJMC: Bridging the Gap Between Cutting-Edge Cancer Care and Equitable Access

Drug Store News: EmblemHealth taps Amazon Pharmacy for new pharmacy benefit

Managed Healthcare Executive: Automated Prior Authorization Speeds Approval of GLP-1 Therapies | AMCP Nexus 2025

Managed Healthcare Executive: Payers Are Bracing for the Specialty Trend of the Future | AMCP Nexus 2025

Fierce Healthcare: Prime Therapeutics takes Sempre Health's pricing model nationwide

High-Cost Therapy Profile: November 2025

Oncology Insights: November 2025

Cell & Gene Pipeline Outlook: November 2025

Trending Topics & Drug Approvals: November 2025

Five research posters presented at AMCP Nexus 2025

Quarterly Drug Approvals: October 2025

Login Portals

Compliance / Legal

Company

Read – News, Research & Insights from Prime Therapeutics - Prime Therapeutics